For a third time in recent weeks, a drug company has announced that its vaccine candidate is effective in clinical trials. Now AstraZeneca joins Pfizer and its German partner, BioNTech, along with Moderna in reporting their results.
Here locally the Moderna and Pfizer vaccine trials are underway. Ohio Gov. Mike DeWine announced Tuesday that vaccines could begin arriving as soon as Dec. 15.
So, what does this mean? How soon will a vaccine rollout in the U.S. and when can you expect your first dose?
Joining Cincinnati Edition to discuss are University of Cincinnati Professor of Infectious Diseases Carl Fichtenbaum, MD; and Cincy Tech Managing Director of Life Sciences John Rice, Ph.D. Dr. Fichtenbaum is co-investigator and medical director for the Moderna study at UC. John Rice is a patient in the Pfizer trial at Cincinnati Children's Hospital.
Listen to Cincinnati Edition live at noon M-F. Audio for this segment will be uploaded after 4 p.m. ET.
Never miss an episode by subscribing to our podcast: